BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 38668052)

  • 1. The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review.
    Smorodin E; Chuzmarov V; Veidebaum T
    Curr Oncol; 2024 Apr; 31(4):1994-2023. PubMed ID: 38668052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin increase as predictor for tumor objective response to chemotherapy in advanced cancer patients.
    Lissoni P; Tancini G; Barni S; Crispino S; Paolorossi F; Rovelli F; Cattaneo G; Fraschini F
    Tumori; 1988 Jun; 74(3):339-45. PubMed ID: 3400124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin May Increase Anticancer Potential of Pleiotropic Drugs.
    Bojková B; Kubatka P; Qaradakhi T; Zulli A; Kajo K
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy with melatonin for targeting human cancers: A review.
    Najafi M; Salehi E; Farhood B; Nashtaei MS; Hashemi Goradel N; Khanlarkhani N; Namjoo Z; Mortezaee K
    J Cell Physiol; 2019 Mar; 234(3):2356-2372. PubMed ID: 30192001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study.
    Lissoni P; Tancini G; Paolorossi F; Mandalà M; Ardizzoia A; Malugani F; Giani L; Barni S
    J Pineal Res; 1999 Apr; 26(3):169-73. PubMed ID: 10231730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state.
    Lissoni P; Paolorossi F; Ardizzoia A; Barni S; Chilelli M; Mancuso M; Tancini G; Conti A; Maestroni GJ
    J Pineal Res; 1997 Aug; 23(1):15-9. PubMed ID: 9379341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone.
    Lissoni P; Cazzaniga M; Tancini G; Scardino E; Musci R; Barni S; Maffezzini M; Meroni T; Rocco F; Conti A; Maestroni G
    Eur Urol; 1997; 31(2):178-81. PubMed ID: 9076462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy.
    Mafi A; Rezaee M; Hedayati N; Hogan SD; Reiter RJ; Aarabi MH; Asemi Z
    Cell Commun Signal; 2023 Feb; 21(1):33. PubMed ID: 36759799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of melatonin in oncology: Focus on colorectal cancer.
    Gil-Martín E; Egea J; Reiter RJ; Romero A
    Med Res Rev; 2019 Nov; 39(6):2239-2285. PubMed ID: 30950095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronobiology, cognitive function and depressive symptoms in surgical patients.
    Hansen MV
    Dan Med J; 2014 Sep; 61(9):B4914. PubMed ID: 25186550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for melatonin in supportive care?
    Lissoni P
    Support Care Cancer; 2002 Mar; 10(2):110-6. PubMed ID: 11862501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary studies on melatonin in the treatment of myelodysplastic syndromes following cancer chemotherapy.
    Viviani S; Negretti E; Orazi A; Sozzi G; Santoro A; Lissoni P; Esposti G; Fraschini F
    J Pineal Res; 1990; 8(4):347-54. PubMed ID: 2395074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status.
    Lissoni P; Barni S; Mandalà M; Ardizzoia A; Paolorossi F; Vaghi M; Longarini R; Malugani F; Tancini G
    Eur J Cancer; 1999 Nov; 35(12):1688-92. PubMed ID: 10674014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
    Cerea G; Vaghi M; Ardizzoia A; Villa S; Bucovec R; Mengo S; Gardani G; Tancini G; Lissoni P
    Anticancer Res; 2003; 23(2C):1951-4. PubMed ID: 12820485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Melatonin on Colon Cancer Cells' Resistance to Doxorubicin in an in Vitro Study.
    Fic M; Gomulkiewicz A; Grzegrzolka J; Podhorska-Okolow M; Zabel M; Dziegiel P; Jablonska K
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28788434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Melatonin in Colorectal Cancer.
    Iravani S; Eslami P; Dooghaie Moghadam A; Moazzami B; Mehrvar A; Hashemi MR; Mansour-Ghanaei F; Mansour-Ghanaei A; Majidzadeh-A K
    J Gastrointest Cancer; 2020 Sep; 51(3):748-753. PubMed ID: 31792737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates.
    Barni S; Lissoni P; Cazzaniga M; Ardizzoia A; Meregalli S; Fossati V; Fumagalli L; Brivio F; Tancini G
    Oncology; 1995; 52(3):243-5. PubMed ID: 7715908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin.
    Lissoni P; Tancini G; Barni S; Paolorossi F; Ardizzoia A; Conti A; Maestroni G
    Support Care Cancer; 1997 Mar; 5(2):126-9. PubMed ID: 9069612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and Integrative Medicine to Reduce Adverse Effects of Anticancer Therapy.
    Rossi E; Noberasco C; Picchi M; Stefano MD; Rossi A; Nurra L; Ventura L
    J Altern Complement Med; 2018; 24(9-10):933-941. PubMed ID: 30247968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.